List of Tables
Table 1. Global Complementary Therapy Lacosamide Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Complementary Therapy Lacosamide Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Complementary Therapy Lacosamide Market Competitive Situation by Manufacturers in 2024
Table 4. Global Complementary Therapy Lacosamide Sales (Units) of Key Manufacturers (2020-2025)
Table 5. Global Complementary Therapy Lacosamide Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Complementary Therapy Lacosamide Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Complementary Therapy Lacosamide Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Complementary Therapy Lacosamide Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Complementary Therapy Lacosamide, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Complementary Therapy Lacosamide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Complementary Therapy Lacosamide, Product Type & Application
Table 12. Global Key Manufacturers of Complementary Therapy Lacosamide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Complementary Therapy Lacosamide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complementary Therapy Lacosamide as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Complementary Therapy Lacosamide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Complementary Therapy Lacosamide Sales by Region (2020-2025) & (Units)
Table 18. Global Complementary Therapy Lacosamide Sales Market Share by Region (2020-2025)
Table 19. Global Complementary Therapy Lacosamide Sales by Region (2026-2031) & (Units)
Table 20. Global Complementary Therapy Lacosamide Sales Market Share by Region (2026-2031)
Table 21. Global Complementary Therapy Lacosamide Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Complementary Therapy Lacosamide Revenue Market Share by Region (2020-2025)
Table 23. Global Complementary Therapy Lacosamide Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Complementary Therapy Lacosamide Revenue Market Share by Region (2026-2031)
Table 25. North America Complementary Therapy Lacosamide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Complementary Therapy Lacosamide Sales by Country (2020-2025) & (Units)
Table 27. North America Complementary Therapy Lacosamide Sales by Country (2026-2031) & (Units)
Table 28. North America Complementary Therapy Lacosamide Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Complementary Therapy Lacosamide Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Complementary Therapy Lacosamide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Complementary Therapy Lacosamide Sales by Country (2020-2025) & (Units)
Table 32. Europe Complementary Therapy Lacosamide Sales by Country (2026-2031) & (Units)
Table 33. Europe Complementary Therapy Lacosamide Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Complementary Therapy Lacosamide Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Complementary Therapy Lacosamide Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Complementary Therapy Lacosamide Sales by Region (2020-2025) & (Units)
Table 37. Asia Pacific Complementary Therapy Lacosamide Sales by Region (2026-2031) & (Units)
Table 38. Asia Pacific Complementary Therapy Lacosamide Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Complementary Therapy Lacosamide Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Complementary Therapy Lacosamide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Complementary Therapy Lacosamide Sales by Country (2020-2025) & (Units)
Table 42. Latin America Complementary Therapy Lacosamide Sales by Country (2026-2031) & (Units)
Table 43. Latin America Complementary Therapy Lacosamide Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Complementary Therapy Lacosamide Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Complementary Therapy Lacosamide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Complementary Therapy Lacosamide Sales by Country (2020-2025) & (Units)
Table 47. Middle East and Africa Complementary Therapy Lacosamide Sales by Country (2026-2031) & (Units)
Table 48. Middle East and Africa Complementary Therapy Lacosamide Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Complementary Therapy Lacosamide Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Complementary Therapy Lacosamide Sales (Units) by Type (2020-2025)
Table 51. Global Complementary Therapy Lacosamide Sales (Units) by Type (2026-2031)
Table 52. Global Complementary Therapy Lacosamide Sales Market Share by Type (2020-2025)
Table 53. Global Complementary Therapy Lacosamide Sales Market Share by Type (2026-2031)
Table 54. Global Complementary Therapy Lacosamide Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Complementary Therapy Lacosamide Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Complementary Therapy Lacosamide Revenue Market Share by Type (2020-2025)
Table 57. Global Complementary Therapy Lacosamide Revenue Market Share by Type (2026-2031)
Table 58. Global Complementary Therapy Lacosamide Price (US$/Unit) by Type (2020-2025)
Table 59. Global Complementary Therapy Lacosamide Price (US$/Unit) by Type (2026-2031)
Table 60. Global Complementary Therapy Lacosamide Sales (Units) by Application (2020-2025)
Table 61. Global Complementary Therapy Lacosamide Sales (Units) by Application (2026-2031)
Table 62. Global Complementary Therapy Lacosamide Sales Market Share by Application (2020-2025)
Table 63. Global Complementary Therapy Lacosamide Sales Market Share by Application (2026-2031)
Table 64. Global Complementary Therapy Lacosamide Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Complementary Therapy Lacosamide Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Complementary Therapy Lacosamide Revenue Market Share by Application (2020-2025)
Table 67. Global Complementary Therapy Lacosamide Revenue Market Share by Application (2026-2031)
Table 68. Global Complementary Therapy Lacosamide Price (US$/Unit) by Application (2020-2025)
Table 69. Global Complementary Therapy Lacosamide Price (US$/Unit) by Application (2026-2031)
Table 70. UCB Company Information
Table 71. UCB Description and Business Overview
Table 72. UCB Complementary Therapy Lacosamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. UCB Complementary Therapy Lacosamide Product
Table 74. UCB Recent Developments/Updates
Table 75. Aesica Pharmaceuticals GmbH Company Information
Table 76. Aesica Pharmaceuticals GmbH Description and Business Overview
Table 77. Aesica Pharmaceuticals GmbH Complementary Therapy Lacosamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Aesica Pharmaceuticals GmbH Complementary Therapy Lacosamide Product
Table 79. Aesica Pharmaceuticals GmbH Recent Developments/Updates
Table 80. Teva Company Information
Table 81. Teva Description and Business Overview
Table 82. Teva Complementary Therapy Lacosamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Teva Complementary Therapy Lacosamide Product
Table 84. Teva Recent Developments/Updates
Table 85. MSN Laboratories Company Information
Table 86. MSN Laboratories Description and Business Overview
Table 87. MSN Laboratories Complementary Therapy Lacosamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. MSN Laboratories Complementary Therapy Lacosamide Product
Table 89. MSN Laboratories Recent Developments/Updates
Table 90. Alembic Pharma Company Information
Table 91. Alembic Pharma Description and Business Overview
Table 92. Alembic Pharma Complementary Therapy Lacosamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Alembic Pharma Complementary Therapy Lacosamide Product
Table 94. Alembic Pharma Recent Developments/Updates
Table 95. Glenmark Company Information
Table 96. Glenmark Description and Business Overview
Table 97. Glenmark Complementary Therapy Lacosamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Glenmark Complementary Therapy Lacosamide Product
Table 99. Glenmark Recent Developments/Updates
Table 100. Accord Healthcare Company Information
Table 101. Accord Healthcare Description and Business Overview
Table 102. Accord Healthcare Complementary Therapy Lacosamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Accord Healthcare Complementary Therapy Lacosamide Product
Table 104. Accord Healthcare Recent Developments/Updates
Table 105. Mylan Company Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Complementary Therapy Lacosamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Mylan Complementary Therapy Lacosamide Product
Table 109. Mylan Recent Developments/Updates
Table 110. Sun PharmaApotex Company Information
Table 111. Sun PharmaApotex Description and Business Overview
Table 112. Sun PharmaApotex Complementary Therapy Lacosamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Sun PharmaApotex Complementary Therapy Lacosamide Product
Table 114. Sun PharmaApotex Recent Developments/Updates
Table 115. Camber Pharmaceuticals Company Information
Table 116. Camber Pharmaceuticals Description and Business Overview
Table 117. Camber Pharmaceuticals Complementary Therapy Lacosamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Camber Pharmaceuticals Complementary Therapy Lacosamide Product
Table 119. Camber Pharmaceuticals Recent Developments/Updates
Table 120. Fresenius Group Company Information
Table 121. Fresenius Group Description and Business Overview
Table 122. Fresenius Group Complementary Therapy Lacosamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Fresenius Group Complementary Therapy Lacosamide Product
Table 124. Fresenius Group Recent Developments/Updates
Table 125. Jiangxi Qingfeng Pharmaceutical Industry Company Information
Table 126. Jiangxi Qingfeng Pharmaceutical Industry Description and Business Overview
Table 127. Jiangxi Qingfeng Pharmaceutical Industry Complementary Therapy Lacosamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Jiangxi Qingfeng Pharmaceutical Industry Complementary Therapy Lacosamide Product
Table 129. Jiangxi Qingfeng Pharmaceutical Industry Recent Developments/Updates
Table 130. Sihuan Pharmaceutical Holdings Group Company Information
Table 131. Sihuan Pharmaceutical Holdings Group Description and Business Overview
Table 132. Sihuan Pharmaceutical Holdings Group Complementary Therapy Lacosamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Sihuan Pharmaceutical Holdings Group Complementary Therapy Lacosamide Product
Table 134. Sihuan Pharmaceutical Holdings Group Recent Developments/Updates
Table 135. Shandong Buchang Pharmaceuticals Company Information
Table 136. Shandong Buchang Pharmaceuticals Description and Business Overview
Table 137. Shandong Buchang Pharmaceuticals Complementary Therapy Lacosamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Shandong Buchang Pharmaceuticals Complementary Therapy Lacosamide Product
Table 139. Shandong Buchang Pharmaceuticals Recent Developments/Updates
Table 140. Sichuan Aupone Pharmaceutical Company Information
Table 141. Sichuan Aupone Pharmaceutical Description and Business Overview
Table 142. Sichuan Aupone Pharmaceutical Complementary Therapy Lacosamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Sichuan Aupone Pharmaceutical Complementary Therapy Lacosamide Product
Table 144. Sichuan Aupone Pharmaceutical Recent Developments/Updates
Table 145. Yifan Pharmaceutical Company Information
Table 146. Yifan Pharmaceutical Description and Business Overview
Table 147. Yifan Pharmaceutical Complementary Therapy Lacosamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Yifan Pharmaceutical Complementary Therapy Lacosamide Product
Table 149. Yifan Pharmaceutical Recent Developments/Updates
Table 150. Jiangsu Haian Pharmaceutical Company Information
Table 151. Jiangsu Haian Pharmaceutical Description and Business Overview
Table 152. Jiangsu Haian Pharmaceutical Complementary Therapy Lacosamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Jiangsu Haian Pharmaceutical Complementary Therapy Lacosamide Product
Table 154. Jiangsu Haian Pharmaceutical Recent Developments/Updates
Table 155. Jiangxi Kerui Pharmaceutical Company Information
Table 156. Jiangxi Kerui Pharmaceutical Description and Business Overview
Table 157. Jiangxi Kerui Pharmaceutical Complementary Therapy Lacosamide Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Jiangxi Kerui Pharmaceutical Complementary Therapy Lacosamide Product
Table 159. Jiangxi Kerui Pharmaceutical Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Complementary Therapy Lacosamide Distributors List
Table 163. Complementary Therapy Lacosamide Customers List
Table 164. Complementary Therapy Lacosamide Market Trends
Table 165. Complementary Therapy Lacosamide Market Drivers
Table 166. Complementary Therapy Lacosamide Market Challenges
Table 167. Complementary Therapy Lacosamide Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Complementary Therapy Lacosamide
Figure 2. Global Complementary Therapy Lacosamide Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Complementary Therapy Lacosamide Market Share by Type: 2024 & 2031
Figure 4. Injection Solution Product Picture
Figure 5. Piece Product Picture
Figure 6. Global Complementary Therapy Lacosamide Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Complementary Therapy Lacosamide Market Share by Application: 2024 & 2031
Figure 8. Public Hospital
Figure 9. Private Hospital
Figure 10. Global Complementary Therapy Lacosamide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Complementary Therapy Lacosamide Market Size (2020-2031) & (US$ Million)
Figure 12. Global Complementary Therapy Lacosamide Sales (2020-2031) & (Units)
Figure 13. Global Complementary Therapy Lacosamide Average Price (US$/Unit) & (2020-2031)
Figure 14. Complementary Therapy Lacosamide Report Years Considered
Figure 15. Complementary Therapy Lacosamide Sales Share by Manufacturers in 2024
Figure 16. Global Complementary Therapy Lacosamide Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Complementary Therapy Lacosamide Players: Market Share by Revenue in Complementary Therapy Lacosamide in 2024
Figure 18. Complementary Therapy Lacosamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Complementary Therapy Lacosamide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Complementary Therapy Lacosamide Sales Market Share by Country (2020-2031)
Figure 21. North America Complementary Therapy Lacosamide Revenue Market Share by Country (2020-2031)
Figure 22. United States Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Complementary Therapy Lacosamide Sales Market Share by Country (2020-2031)
Figure 25. Europe Complementary Therapy Lacosamide Revenue Market Share by Country (2020-2031)
Figure 26. Germany Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Complementary Therapy Lacosamide Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Complementary Therapy Lacosamide Revenue Market Share by Region (2020-2031)
Figure 33. China Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Latin America Complementary Therapy Lacosamide Sales Market Share by Country (2020-2031)
Figure 41. Latin America Complementary Therapy Lacosamide Revenue Market Share by Country (2020-2031)
Figure 42. Mexico Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Brazil Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Argentina Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Middle East and Africa Complementary Therapy Lacosamide Sales Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Complementary Therapy Lacosamide Revenue Market Share by Country (2020-2031)
Figure 47. Turkey Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. UAE Complementary Therapy Lacosamide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Global Sales Market Share of Complementary Therapy Lacosamide by Type (2020-2031)
Figure 51. Global Revenue Market Share of Complementary Therapy Lacosamide by Type (2020-2031)
Figure 52. Global Complementary Therapy Lacosamide Price (US$/Unit) by Type (2020-2031)
Figure 53. Global Sales Market Share of Complementary Therapy Lacosamide by Application (2020-2031)
Figure 54. Global Revenue Market Share of Complementary Therapy Lacosamide by Application (2020-2031)
Figure 55. Global Complementary Therapy Lacosamide Price (US$/Unit) by Application (2020-2031)
Figure 56. Complementary Therapy Lacosamide Value Chain
Figure 57. Channels of Distribution (Direct Vs Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
